Anu G. Gaba
Expertise in
21
conditions

Dr. Anu G. Gaba

Hematology | Oncology
Sanford Health Detroit Lakes Clinic &Amp; Same Day Surgery Center
1245 Washington Ave., 
Detroit Lakes, MN 
Accepting New Patients
Offers Telehealth
Expertise in
21
conditions
Sanford Health Detroit Lakes Clinic &Amp; Same Day Surgery Center
1245 Washington Ave., 
Detroit Lakes, MN 

Overview

Dr. Anu Gaba specializes in oncology and hematology. She treats: Dr. Gaba is a member of the Edith Sanford Breast Center Physician Leadership Council, a physician-led, multidisciplinary group designed to help direct efforts for optimal breast health care. Listen to Dr. Anu Gaba on Sanford Health’s One in Eight podcast where she explains exactly what is breast cancer research . Speaks: English.

Dr. Gaba is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Gaba is board certified in American Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: OncologyAmerican Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials. Dr. Gaba is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in ND

Board Certifications

American Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: OncologyAmerican Board Of Internal Medicine

Fellowships

Montefiore Medical Center, Hematology/Oncology

Hospital Affiliations

Sanford Bemidji Medical Center
Sanford Medical Center Fargo
Sanford Hillsboro
Perham Health
Jamestown Regional Medical Center

Languages Spoken

English
Hindi

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Sanford Health Detroit Lakes Clinic & Same Day Surgery Center
1245 Washington Ave., Detroit Lakes, MN 56501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and Safety of Niraparib to Placebo in Participants With Either HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer With Molecular Disease Based on Presence of Circulating Tumor DNA After Definitive Therapy (ZEST)
A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and Safety of Niraparib to Placebo in Participants With Either HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer With Molecular Disease Based on Presence of Circulating Tumor DNA After Definitive Therapy (ZEST)
Enrollment Status: Active_not_recruiting
Publish Date: July 16, 2025
Intervention Type: Drug
Study Drug: Niraparib
Study Phase: Phase 3
View 1 Less Clinical Trial

15 Total Publications

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: April 22, 2026
Similar Doctors
Expertise in
47
conditions
Dr. Matthew J. Tinguely
Hematology | Oncology
Expertise in
47
conditions
Dr. Matthew J. Tinguely
Hematology | Oncology
Referral may be required

Sanford Roger Maris Cancer Center

820 Fourth St. N., 
Fargo, ND 
 (47.4 miles away)
701-234-6161
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Speaks: English. Dr. Tinguely is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Tinguely is board certified in American Board Of Internal Medicine: OncologyAmerican Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: Internal Medicine. Dr. Tinguely is currently accepting new patients.

Expertise in
47
conditions
Dr. Mahendra K. Gupta
Oncology | Hematology
Expertise in
47
conditions
Dr. Mahendra K. Gupta
Oncology | Hematology
Referral may be required

Sanford Roger Maris Cancer Center

820 Fourth St. N., 
Fargo, ND 
 (47.4 miles away)
701-234-6161
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Speaks: English. Dr. Gupta is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Gupta is board certified in American Board Of Internal Medicine: OncologyAmerican Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: Internal Medicine. Dr. Gupta is currently accepting new patients.

Expertise in
36
conditions
Dr. Radhakrishna R. Vegunta
Oncology | Hematology
Expertise in
36
conditions
Dr. Radhakrishna R. Vegunta
Oncology | Hematology
Referral may be required

Sanford Roger Maris Cancer Center

820 Fourth St. N., 
Fargo, ND 
 (47.4 miles away)
701-234-6161
Languages Spoken:
English, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Speaks: English, Telugu. Dr. Vegunta is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Bone Marrow Aspiration. Dr. Vegunta is board certified in American Board Of Internal Medicine: HematologyAmerican Board Of Internal Medicine: Medical OncologyAmerican Board Of Internal Medicine: Internal Medicine. Dr. Vegunta is currently accepting new patients.

Frequently Asked Questions about Dr. Anu G. Gaba

How do I make an appointment with Dr. Anu G. Gaba?

You can book an appointment with Dr. Anu G. Gaba by calling their office at 218-846-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anu G. Gaba a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anu G. Gaba is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anu G. Gaba specialize in?

While Dr. Anu G. Gaba is a Hematology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Anu G. Gaba participate in research or clinical trials?

Yes. Dr. Anu G. Gaba has published 15 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Anu G. Gaba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Anu G. Gaba accept my insurance?

Dr. Anu G. Gaba accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 218-846-2000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gaba's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 125 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile